Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Huntington's and astrocytes: no good guys, bad guys

Oct. 23, 2019

Biogen to pursue regulatory filing for aducanumab in early Alzheimer's disease

Oct. 22, 2019

i2020 Accelerator invests in research program at University of Turku for neurodegenerative diseases

Oct. 22, 2019

C-781: a promising compound for mechanical allodynia

Oct. 22, 2019

Suven Life Sciences presents preclinical data for SUVN-A6077

Oct. 22, 2019

Metabolic problems are early event in Alzheimer's

Oct. 22, 2019

Enhancing PGK1 activity and increasing glycolysis may slow neurodegeneration in Parkinson's disease

Oct. 18, 2019

Brain axonal iron transport modulates anxiety-related behaviors

Oct. 18, 2019

First patient dosed in phase II study of IMB-115

Oct. 18, 2019

UniQure enrolling patients with early manifest Huntington's disease for phase I/II study of AMT-130

Oct. 17, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
Genescience presents STAT6 degrader for atopic dermatitis
BioWorld Science
Genescience Pharmaceutical Co. Ltd. has presented data on a new STAT6 PROTAC degrader – GenSciP166 – which selectively targets STAT6 for proteasomal degradation....
Roche reports new TREM2 agonists
BioWorld Science
F. Hoffmann-la Roche Ltd. and Hoffmann-La Roche Inc. have identified new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for...